Literature DB >> 16823830

Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study.

M Voulgarelis1, S Giannouli, A Tasidou, D Anagnostou, P D Ziakas, A G Tzioufas.   

Abstract

BACKGROUND: The histopathologic features characterizing the involvement of the bone marrow (BM) in systemic lupus erythematosus (SLE) have not been systematically analyzed to date.
OBJECTIVES: The aim of this study was to assess morphologic and immunohistochemical characteristics of BM involvement in SLE. PATIENTS AND METHODS: Clinical and serological data of 40 SLE patients with unexplained cytopenias were studied. Ten patients with myelodysplasia of refractory anemia (RA) were used as controls. BM aspiration, BM biopsy (BMB), and immunohistochemistry were carried out in patients and controls. BM fibrosis, BM necrosis, stromal edema, and abnormal localization of immature precursors (ALIP) were assessed according to standard criteria.
RESULTS: Dyserythropoiesis and megakaryocytic atypias were uniform findings in SLE patients. The disruption of the normal BM architecture was a predominant SLE BM feature affecting cells of all three hemopoietic lineages, with both erythroid and megakaryocytic precursors tending to assume paratrabecular locations and ALIP aggregates being present in 27 cases. In addition, BM was hypocellular in 23 cases. BM necrotic alterations were evident in 90% of the cases. The density of reticulin content was generally increased. Vascular changes including dilatation of sinuses were manifest and were associated with the presence of necrotic alterations (P = 0.008). Hemoglobin levels correlated inversely with the presence of ALIP (P = 0.016). Upon comparing BMB features between SLE and RA controls there were striking similarities.
CONCLUSIONS: BMB in patients with SLE and unexplained cytopenias presents a variety of histopathologic findings including BM necrosis, stromal alterations, hypocellularity, dyspoiesis, and distortion of normal BM architecture, characterized primarily by the presence of ALIP aggregates.

Entities:  

Mesh:

Year:  2006        PMID: 16823830     DOI: 10.1002/ajh.20593

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  17 in total

1.  Toll-like receptor 7-stimulated tumor necrosis factor α causes bone marrow damage in systemic lupus erythematosus.

Authors:  Haoyang Zhuang; Shuhong Han; Yuan Xu; Yi Li; Hai Wang; Li-Jun Yang; Westley H Reeves
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

2.  [Rationale for bone marrow examination in patients with inflammatory rheumatic diseases].

Authors:  Jutta G Richter; Pascal Gossen; Ulrich Germing; Sabine Blum; Barbara Hildebrandt; Stefan Braunstein; Dörte Huscher; Matthias Schneider
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Aplastic anemia associated to systemic lupus erythematosus in an AIDS patient: a case report.

Authors:  Leonardo Rodrigues de Oliveira; Thaís Camargos Ferreira; Fernando de Freitas Neves; Antônio Carlos de Oliveira Meneses
Journal:  Rev Bras Hematol Hemoter       Date:  2013

4.  Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures.

Authors:  Magdalene Nakou; Nicholas Knowlton; Mark B Frank; George Bertsias; Jeanette Osban; Clayton E Sandel; Helen Papadaki; Amalia Raptopoulou; Prodromos Sidiropoulos; Iraklis Kritikos; Ioannis Tassiulas; Michael Centola; Dimitrios T Boumpas
Journal:  Arthritis Rheum       Date:  2008-11

5.  Autoimmune Myelofibrosis in Systemic Lupus Erythematosus Report of Two Cases and Review of the Literature.

Authors:  Prasad R Koduri; Mohammad Parvez; Sashidhar Kaza; S Vanajakshi
Journal:  Indian J Hematol Blood Transfus       Date:  2015-02-15       Impact factor: 0.900

6.  A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.

Authors:  Hava Ben-David; Amir Sharabi; Reshmi Parameswaran; Heidy Zinger; Edna Mozes
Journal:  Immunology       Date:  2009-10       Impact factor: 7.397

7.  The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability.

Authors:  József Prechl; László Czirják
Journal:  F1000Res       Date:  2015-01-26

8.  Autoimmunity-associated protein tyrosine phosphatase PEP negatively regulates IFN-α receptor signaling.

Authors:  Derek A Holmes; Eric Suto; Wyne P Lee; Qinglin Ou; Qian Gong; Hamish R C Smith; Patrick Caplazi; Andrew C Chan
Journal:  J Exp Med       Date:  2015-06-15       Impact factor: 14.307

9.  Clustered precursors in bone marrow sections predict early relapse in patients with acute myeloid leukemia within hematologic remission.

Authors:  Yehua Yu; Zhentian Wu; Jing Zhang; Yuanmei Zhai; Yinghua Yuan; Sihong Liu; Hui Wang; Jun Shi
Journal:  J Transl Med       Date:  2014-01-22       Impact factor: 5.531

10.  Bone marrow injury induced via oxidative stress in mice by inhalation exposure to formaldehyde.

Authors:  Yuchao Zhang; Xudong Liu; Cliona McHale; Rui Li; Luoping Zhang; Yang Wu; Xin Ye; Xu Yang; Shumao Ding
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.